A previous study showed that lncRNA down-regulated in liver cancer stem cells (lncRNA DILC) regulated behaviors of liver cancer stem cells via IL-6/STAT3 axis [21], so we supposed that lncRNA DILC might be associated with the progression of neuropathic pain through regulating STAT3 activation. The gene discussed is STAT3; the disease is liver cancer.